Member Info for AB124

Have a look at the 20d MA.....

RuckRover
Good idea
Will come back later.

hasiba,
I'll echo RucRovers comment.
Please be assured that I believe who you say you are and you have made the purchases you have said you have.
I'm simply intrigued to understand why you would publish your intentions when your experience in investment suggests you might do otherwise.
Hope an open disussion is OK with you if not some others!
Good luck with the build.

hasiba
Looks to me like you hope that nothing happens for at least six months. if you want to acquire your target of 1% of Scancell issued you'll have to buy 50K per day for the next six months at least. A few days of that and you'll be buying against yourself, and what happens when there is a spike? You are very unusual in being a shrewd operator who wants to acquire a substantial holding and then announces he's buying on dips. Doesn't that work against your plan a little?
I am interested in why you announce your intention to buy a lot of shares and then post that nothing's likely to happen for six months. Be careful, because you'll be accused of wanting to influence people so you can buy cheaply by some around here.
Strikes me you'll be in trouble on two fromts for being honest.
A six month run of buying 50K per day?... surely people will notice?

Chelsea7
Thank you for your further comments which are so off topic for this thread that I'll leave them as they are.

Chelsea7
Thankyou for your comment on insolvency but I think you'll find that Ratcliffewriter was making wider comment about such matters in the priceless thread. I write this here to reply to your 23.27.

Thought I'd have a look here before turning in and I see things have moved on to insolvency. I would be amazed if Scancell ever got to that point. In fact it would be pretty well unthinkable if the science is of the quality we investors generally believe it to be. So to start thinking of how the company would be wound up surprises me, but I guess some might like to consider it.
I'm still happy to stay with the patience/patients route and worry about a full collapse should there be any reason to do so. I reckon there would be interest in the residual assets of the company assuming not every platform's trials ended in complete failure.
In my opinion patience is a virtue!
Night all...

Where is Beruda?
Bermudashorts...LOL

Berudashorts
I certainly can't argue with your comments regarding the second tranche. As you say it could be that straightforward.

hasiba
If the IP has no value why are there so many calls for the share price in Scancell to be higher than it is at present?
The IP is the value here, the key to unlock it is commercialisation.
Since the Company have failed to commercialise the IP to date does that mean the IP has no value? Of course not. The IP value is diminished or wiped out if the trials fail. Even then the underlying science and platforms are not necessarily worthless.
A cash strapped Scancell with incomplete or badly set up and conducted trials could be a failed company, but te IP could still have value and another might be happy to take the assets on to prove them. Since Redmile could easily acquire a full controlling interest it could sell those assets and recoup some of its investment.
I'm sorry but I dispute you thesis that the IP is necessarily worthless if the company fails.
And please note everyone, I am not saying the trials will fail. I am answering hasiba's somewhat unusual comment.

I am hoping that my posts in this thread will demonstrate my view that for Scancell to succeed in monetising their IP that the likely requirement for all platforms is Data from successful and timely trials.
Once that is available (and hopefully great data) then the commercialisation can begin.
Once that commercialisation can begin then the share price will likely show significant growth... not just a few pence.
To get to that stage as the thread is entitled,
"Patience and Patients seem to be the keywords for investors in scancell ATM".
Hope that clarifies my position.

Hasiba
I didn't say that the IP would retain value after trial failure. I said that if the company failed to commercialse the IP for whstever reason. I made no comment on therapeutic value. The IP of each platform represents the company's assets so thus retain value should they not be commercislised for whatever reason. You should be aware I'm not saying they won't be commercialised..if however they're not Redmile are in a position to save their investment. It should also not be forgotten that Scancell have had eight years to manage SCIB 1 to monetizing status...... but they haven't have they?

Ivyspivey, BermudaShorts,
I wonder whether the second cash inection from Redmile was to secure the IP should Scancell fail to develop or take forward the extisting platforms successfully (as well as giving Scancell suffiecient capital for the immediate needs.
If Vulpes due diligence was exhaustive and if Redmile arrived at a similar conclusion their ability to trigger a rule 9 for the forseeable future would keep them in control of what after say two years without significant deals might look like a rather dismal history for Scancell. By maintaining that control Redmile can protect their investment whilst allowing them influence to "resell" in the US by the possibility of facilitating a Nasdaq listing (unlikely in the "fail" scenario), or even by the option of going private in the US with the (unrealised commercially) IP still intact.
If the Scancell BOD fail to capitalise, a relatively low offer for the remainder of the Company's shares that Redmile don't already old should gain them control of the company relatively inexpensively, as we all know how fickle shareholders can be when faced with a company that doesn't perform and there is a willing buyer for their shares.
It seems to me that Scancell (should they start the deal making sooner rather than later) will provide Redmile with a good return on their capital, and should Scancell fail to do the business Redmile can try again with an asset sale or sales.

Do they not? Yes,I believe so.

WeTook Pelham
The low volume works both ways, small sells and small buys. I would expect that there will be buyers underneath sub 10p but there's no guarantees. Don't forget that lots of small sells allows one big buy!
Those buyers may well be those who sold in the high teens so it's always difficult to establish whether buyers at these levels are new investors or simply bear closers.
But wait until the Data starts to filter through (if it is as good as expected)! then it is a different ball game.
In the meantime it is a wait and see time in my view.

Given the size of the profit (and the physical amounts involved) there's also the question of portfolio weightings and the results of risk analysis.
On top of that Investor (Fund investors that is) returns.
Absolutes are not really appropriate in the Context of Redmile.
I guess it's all horses for courses. and that of course makes a market. Lots of players doing things that suit them at any given time, so there will always be sellers in the good times and buyers in the bad, however daft it might look to an observer. :-)

WeTookPelham,
I'm very happy to let you have my holding right now for only 100% higher than the current share price to save you the trouble and costs of dealing LOL.
But otherwise, like you, I'm still content to wait and see.

RuckRover
Appreciate your comments earlier. I think we have some time to wait for the rewards that I'm sure we all hope will eventually be provided by Scancell's IP. It will be interesting to see where the share price takes us next. Wish I knew! :-)

Chelsea7
I am disappointed that you seem unable to discuss things in a reasonable manner.
I will therefore ask that you make no further comment on any post I make now or in the future.
I will do the same.

RuckRover
If I look at the longer reply from Chelsea7 back to you after mine it seems to suggest that I had written that it was not worth buying until news. I actually wrote quite the reverse in my 16.40 where I particularly wrote that those who want to can get more shares whilst we wait for news!
It's so irritating when clear observations are misrepresented.

40